<DOC>
	<DOCNO>NCT01533428</DOCNO>
	<brief_summary>The purpose study assess efficacy safety single treatment Capsaicin 8 % transdermal delivery system reduce pain damage nerve ( neuropathic pain ) cause diabetes .</brief_summary>
	<brief_title>A Study Evaluate Efficacy Safety Single Application Capsaicin 8 % Transdermal Delivery System Compared Placebo Reducing Pain Intensity Subjects With Painful Diabetic Peripheral Neuropathy ( PDPN )</brief_title>
	<detailed_description>Participants divide 2 group approximately equal size . In first group , participant receive Capsaicin 8 % patch apply 30 minute foot ; second group , participant receive placebo patch apply 30 minute foot . Participants involve study approximately 12 week visit clinic approximately 6 time .</detailed_description>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<mesh_term>Capsaicin</mesh_term>
	<criteria>Diagnosis painful , distal , symmetrical , sensorimotor polyneuropathy due diabetes , least 1 year prior screen visit Average Numeric Pain Rating Scale ( NPRS ) score last 24 hour â‰¥4 screen baseline visit Primary pain associate PDPN ( Painful Diabetic Peripheral Neuropathy ) ankles Pain could clearly differentiate , condition might interfere assessment PDPN ( Painful Diabetic Peripheral Neuropathy ) , neurological disorder unrelated diabetic neuropathy ( e.g. , phantom limb pain amputation ) ; skin condition area neuropathy could alter sensation ( e.g. , plantar ulcer ) Current previous foot ulcer determine medical history medical examination Any amputation low extremity Severe renal disease define creatinine clearance &lt; 30 ml/min calculate accord CockcroftGault formula Clinically significant cardiovascular disease within 6 month prior screen visit define cerebrovascular accident , unstable poorly control hypertension , transient ischemic attack , myocardial infarction , unstable angina , current arrhythmia , heart surgery include coronary artery bypass graft surgery , percutaneous coronary angioplasty/stent placement , valvular heart disease Significant peripheral vascular disease ( intermittent claudication lack pulsation either dorsalis pedis posterior tibial artery , anklebrachial systolic blood pressure index &lt; 0.80 ) Clinically significant foot deformity , include hallux rigidus , hallux valgus , rigid toe determine physical examination judge investigator Clinically significant ongoing , uncontrolled untreated abnormality cardiac , renal , hepatic , pulmonary function may interfere either ability complete study evaluation adverse event Diagnosis poorly control major psychiatric disorder Active substance abuse history chronic substance abuse within 1 year prior screen visit prior chronic substance abuse ( include alcoholism ) likely reoccur study period judge investigator Hypersensitivity capsaicin ( i.e. , chili pepper overthecounter [ OTC ] capsaicin product ) , Capsaicin 8 % transdermal delivery system excipients , Eutectic Mixture Local Anaesthetics ( EMLA ) ingredients adhesive Use topical pain medication , nonsteroidal antiinflammatory drug , menthol , methyl salicylate , local anesthetic , steroid capsaicin product painful area within 7 day precede first patch application baseline visit Use oral transdermal opioids exceed total daily dose morphine 80 mg/day , equivalent ; parenteral opioids , regardless dose , within 7 day precede first patch application baseline visit Skin area treat Capsaicin 8 % transdermal delivery system show change crust ulcer Planned elective surgery trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Painful Diabetic Peripheral Neuropathy ,</keyword>
	<keyword>Capsaicin 8 % transdermal delivery system</keyword>
</DOC>